BACKGROUND/AIM: The aim of the study was to investigate the pattern of association of generic and disease-specific quality of life (QoL) scales with standard clinical outcome variables in Alzheimer's disease (AD). METHODS: The participants were 321 home-living patients with mild AD and their primary caregivers from the Danish Alzheimer Intervention Study. QoL was assessed using the generic EuroQol-5D with visual analogue scale (VAS) and the disease-specific Quality of Life in Alzheimer's Disease (QOL-AD) scales (both caregiver and patient rated). Depression, activities of daily living, cognitive performance and neuropsychiatric symptom severity were also assessed. RESULTS: All 3 caregiver-rated QoL scales correlated significantly with each other (p < 0.001) and with clinical measures. Patient-rated QoL versions correlated inversely with depression (p < 0.001) but not significantly with any other clinical variables. CONCLUSION: The caregiver-rated QoL scales showed stronger interscale correlation as well as a similar correlation pattern with standard clinical outcome variables compared to the patient-rated versions. There is some indication that the EQ-5D + VAS could be a suitable alternative to the QOL-AD scale in specific research designs.
BACKGROUND/AIM: The aim of the study was to investigate the pattern of association of generic and disease-specific quality of life (QoL) scales with standard clinical outcome variables in Alzheimer's disease (AD). METHODS: The participants were 321 home-living patients with mild AD and their primary caregivers from the Danish Alzheimer Intervention Study. QoL was assessed using the generic EuroQol-5D with visual analogue scale (VAS) and the disease-specific Quality of Life in Alzheimer's Disease (QOL-AD) scales (both caregiver and patient rated). Depression, activities of daily living, cognitive performance and neuropsychiatric symptom severity were also assessed. RESULTS: All 3 caregiver-rated QoL scales correlated significantly with each other (p < 0.001) and with clinical measures. Patient-rated QoL versions correlated inversely with depression (p < 0.001) but not significantly with any other clinical variables. CONCLUSION: The caregiver-rated QoL scales showed stronger interscale correlation as well as a similar correlation pattern with standard clinical outcome variables compared to the patient-rated versions. There is some indication that the EQ-5D + VAS could be a suitable alternative to the QOL-AD scale in specific research designs.
Authors: Yin Bun Cheung; Hui Xing Tan; Vivian Wei Wang; Nagaendran Kandiah; Nan Luo; Gerald C H Koh; Hwee Lin Wee Journal: Qual Life Res Date: 2018-09-01 Impact factor: 4.147
Authors: Elizaveta Sopina; Lynn Chenoweth; Tim Luckett; Meera Agar; Georgina M Luscombe; Patricia M Davidson; Constance D Pond; Jane Phillips; Stephen Goodall Journal: Qual Life Res Date: 2018-09-05 Impact factor: 4.147
Authors: Kristin Kahle-Wrobleski; Wenyu Ye; David Henley; Ann Marie Hake; Eric Siemers; Yun-Fei Chen; Hong Liu-Seifert Journal: Alzheimers Dement (Amst) Date: 2016-12-13
Authors: Rikke Søgaard; Jan Sørensen; Frans B Waldorff; Ane Eckermann; Dorte V Buss; Kieu T T Phung; Gunhild Waldemar Journal: BMJ Open Date: 2014-01-15 Impact factor: 2.692
Authors: Jeffrey A Johnson; Fatima Al Sayah; Robert Buzinski; Bonnie Corradetti; Sara N Davison; Meghan J Elliott; Scott Klarenbach; Braden Manns; Kara Schick-Makaroff; Hilary Short; Chandra Thomas; Michael Walsh Journal: BMC Health Serv Res Date: 2020-08-10 Impact factor: 2.655